Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion
August 29th, 2018
8.4K views
Here we present a protocol to perform polysome profiling on the isolated perfused mouse heart. We describe methods for heart perfusion, polysome profiling, and analysis of the polysome fractions with respect to mRNAs, miRNAs, and the polysome proteome.
Overview
This article presents a protocol for conducting polysome profiling on isolated perfused mouse hearts. It details the methods for heart perfusion, polysome profiling, and the analysis of polysome fractions in relation to mRNAs, miRNAs, and the polysome proteome.
Key Study Components
Area of Science
- Neuroscience
- Cardiac Biology
- Protein Synthesis
Background
- Polysome profiling is a technique used to study protein synthesis.
- This method helps identify mRNAs selected for translation.
- It also examines the role of microRNAs in translation regulation.
- The technique can be applied to various organs under stress conditions.
Purpose of Study
- To investigate dynamic protein synthesis in the heart.
- To analyze the polysome proteome involved in translation.
- To provide insights into cardiac responses to stress.
Methods Used
- Isolation of the mouse heart for perfusion.
- Preparation of sucrose gradient solutions for polysome profiling.
- Ultracentrifugation to separate polysome fractions.
- Analysis of mRNAs, miRNAs, and proteins involved in translation.
Main Results
- Identification of mRNAs selected for translation during stress.
- Characterization of microRNAs that may interfere with translation.
- Insights into the proteins contributing to protein translation.
- Potential applications of the method in other organs.
Conclusions
- The protocol provides a valuable tool for studying protein synthesis.
- It enhances understanding of cardiac stress responses.
- The method can be adapted for research in other tissues.
Frequently Asked Questions
What is polysome profiling?
Polysome profiling is a technique used to analyze the translation of mRNAs by separating polysomes based on their size and density.
How does this method contribute to understanding cardiac responses?
It allows researchers to identify which mRNAs and proteins are actively involved in translation during cardiac stress, providing insights into heart function.
Can this technique be applied to other organs?
Yes, while this study focuses on the heart, the method can also be used to study acute stress responses in other organs.
What are the key components analyzed in polysome profiling?
The key components include mRNAs, miRNAs, and the polysome proteome involved in translation.
Who demonstrated the procedure in this article?
The procedure was demonstrated by Miroslava Stastna, a project scientist from Jennifer Van Eyk's laboratory.
Executive Industry Relevance
This method enables biopharma R&D teams to dynamically assess protein translation in disease-relevant systems, providing mechanistic insight into stress-induced pathway modulation. By linking mRNA selection, miRNA interference, and proteomic output under ischemic and reperfusion conditions, it supports target validation and lead identification through functional de-risking of translational regulators. The approach offers predictive confidence in early discovery by revealing how translational control influences cardiac stress response, informing portfolio triage and mechanistic biomarker alignment.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by identifying mRNAs actively selected for translation during ischemia and reperfusion, clarifying pathway engagement.
- Scientific Value: Determines which miRNAs associate with polysomes under stress, enabling functional validation of non-coding regulators as potential targets.
- Operational Value: Provides quantitative fractionation of translating vs. non-translating pools, supporting reproducible assessment of translational efficiency.
Screening & Assay Development
- Scientific Value: Generates fractionated mRNA, miRNA, and proteomic readouts that enable assay standardization for translational screening platforms.
- Operational Value: Facilitates preparation of biologically validated lysates for downstream omics applications, improving scalability of target engagement assays.
- Scientific Value: Allows comparison of translating fractions across conditions, supporting biomarker discovery tied to active protein synthesis.
Translational & Preclinical Research
- Scientific Value: Connects dynamic translation changes to disease-relevant stress models, enabling mechanistic de-risking of targets before preclinical advancement.
- Operational Value: Supports continuity from discovery through preclinical validation by providing a reproducible method to assess translational flux in primary tissue.
- Strategic Value: Informs risk-adjusted decisions by revealing which translational nodes are modulated under pathophysiological stress.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target hypothesis testing through lead identification to preclinical validation, particularly for cardiovascular and stress-response pathways.
- Discovery Biology: Enables hypothesis testing by revealing which mRNAs are recruited to polysomes under ischemic stress, clarifying functional target engagement.
- Screening: Produces fractionation data suitable for assay development, allowing teams to assess compound effects on translational efficiency in a reproducible format.
- Analytics: Delivers quantitative mRNA, miRNA, and proteomic distribution across polysome fractions, enabling statistical comparison of translational states.
- Translational Research: Links molecular translation changes to phenotypic stress responses, supporting biomarker alignment and preclinical continuity.
- Enterprise Reuse: Establishes a reusable polysome profiling workflow applicable across organs and stress models, reducing redundant method development.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by resolving mechanistic ambiguity in translational regulation under stress.
- Operational Value: Enhances reproducibility through standardized sucrose gradient fractionation and TCA-based protein extraction, minimizing variability.
- Strategic Value: Improves go/no-go decisions by identifying dysregulated translational nodes early, reducing late-stage biological risk.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on evidence of active translation modulation in disease models.
Implementation Considerations
- Requires expertise in tissue perfusion, polysome fractionation, and gradient handling to avoid sucrose layer disruption.
- Depends on access to ultracentrifugation with swinging bucket rotor and fraction collector for precise polysome separation.
- Necessitates standardized protocols for TCA precipitation and acetone washing to ensure consistent protein recovery from sucrose-rich fractions.
- Involves optimization across model systems, as polysome stability and ribosomal protein distribution may vary by tissue type.
- Limited by the technical challenge of gradient reproducibility, which demands careful training and quality control for reliable fractionation.
Biopharma FAQs
Why does polysome fractionation matter for target validation?
Polysome fractionation identifies which mRNAs are actively engaged with ribosomes during ischemia and reperfusion, revealing translational targets under stress. This enables functional validation of targets based on their recruitment to translating complexes, increasing confidence in target relevance. It supports mechanistic de-risking by linking mRNA selection to phenotypic stress response in a disease-relevant system.
How does isolating translating vs. non-translating fractions support the discovery pipeline?
Separating heavy (translating) from light and non-translating fractions enables quantitative comparison of mRNA, miRNA, and protein distribution under basal, ischemic, and reperfusion conditions. This isolation allows researchers to assess changes in translational efficiency as a functional readout of pathway modulation. It supports assay development by providing standardized fractions for downstream omics analysis in screening workflows.
What do quantitative miRNA measurements across polysome fractions enable?
Quantitative miRNA distribution across polysome fractions reveals which microRNAs associate with translating mRNAs under stress, indicating their potential to interfere with translation. This measurement helps prioritize miRNAs as regulatory targets or biomarkers in stress response pathways. It enables assessment of post-transcriptional control mechanisms that influence protein synthesis dynamics in preclinical models.
Why do replication requirements matter for cross-functional collaboration?
Replication ensures that polysome fractionation results are consistent across experiments, which is essential for building confidence in translational targets among discovery, screening, and preclinical teams. Reliable fractionation supports assay handoff and data comparison between groups working on target validation and lead optimization. Standardized replication reduces variability, enabling multi-site use of the method in enterprise R&D settings.
What statistical analysis capabilities are required before implementing polysome profiling?
Teams require the ability to compare mRNA, miRNA, and protein abundance across polysome fractions using normalized ratios or spectral counts to detect significant shifts between conditions. Statistical tools must support comparison of translating vs. non-translating pools to assess changes in translational efficiency. Implementation depends on having bioinformatics support for omics data analysis from fractionated samples to enable target prioritization and pathway analysis.
